IL17A and Chronic colitis: In addition, in a study using a chronic colitis mice model, IL-10 suppressed the inflammasome/IL-1β pathway, reduced the pathogenicity of Th17 cells, and suppressed IL-17 production, leading to the mitigation of intestinal inflammation [58].